Details for Patent: 7,695,734
✉ Email this page to a colleague
Which drugs does patent 7,695,734 protect, and when does it expire?
Patent 7,695,734 protects MIRAPEX ER and is included in one NDA.
This patent has eighty-three patent family members in thirty-one countries.
Summary for Patent: 7,695,734
Title: | Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof |
Abstract: | An extended release tablet formulation comprising pramipexole or a pharmaceutically acceptable salt thereof in a matrix comprising at least one water swelling polymer other than pregelatinized starch. |
Inventor(s): | Friedl; Thomas (Ochsenhausen, DE), Eisenreich; Wolfram (Ulm, DE) |
Assignee: | Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) |
Application Number: | 11/202,713 |
Patent Claim Types: see list of patent claims | Formulation; Compound; Dosage form; Composition; Use; Process; |
Drugs Protected by US Patent 7,695,734
Foreign Priority and PCT Information for Patent: 7,695,734
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
04019248 | Aug 13, 2004 |
International Family Members for US Patent 7,695,734
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 050602 | ⤷ Try a Trial | |||
Austria | E486588 | ⤷ Try a Trial | |||
Austria | E532503 | ⤷ Try a Trial | |||
Australia | 2005271192 | ⤷ Try a Trial | |||
Australia | 2005271194 | ⤷ Try a Trial | |||
Australia | 2011250676 | ⤷ Try a Trial | |||
Brazil | PI0513846 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |